Double-phase Tc-99m sestamibi scintimammography to assess angiogenesis and P-glycoprotein expression in patients with untreated breast cancer

Clinical Nuclear Medicine

Volumn 24, Issue 5, 1999, Pages 314-318

  Yoon, Jung Han ^a   Bom, Hee Seung ^a   Song, Ho Cheon ^a   Lee, Jae Hyuk ^a   Jaegal, Young Jong ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Angiogenesis; Breast cancer; Double phase Tc 99m sestamibi scintimammography; P glycoprotein

Indexed keywords

GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PROTEIN EXPRESSION; SCINTIMAMMOGRAPHY; TUMOR VASCULARIZATION;

ADULT; AGED; BREAST; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; P-GLYCOPROTEIN; PROSPECTIVE STUDIES; TECHNETIUM TC 99M SESTAMIBI; TUMOR MARKERS, BIOLOGICAL;

EID: 0032943996     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199905000-00003     Document Type: Article

References (16)

1. 99mTc methoxyisobutylisonitrile in imaging breast cancer. Semin Nucl Med 27:40, 1997.
2. Tiling R, Sommer H, Pechmann M, et al: Comparison of technetium-99m MIBI scintimammography with contrast-enhanced MRI for diagnosis of breast lesions. J Nucl Med 38:58, 1997.
3. Piwnica-Worms D, Chiu ML, Budding M, et al: Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 53:977, 1993.
4. Scopinaro F, Schillaci O, Scarpini M, et al: Technetium-99m sestamibi: An indicator of breast cancer invasiveness. Eur J Nucl Med 21:984, 1994.
5. Omar WS, Eissa S, Moustafa H, et al: Role of thallium-201 chloride and Tc-99m methoxy-isobutyl-isonitrile (sestaMIBI) in evaluation of breast masses: Correlation with the immunohistochemical characteristic parameters (Ki-67, PCNA, Bcl, and angiogenesis) in malignant lesions. Anticancer Res 17:1639, 1997.
6. Weidner N: Tumor angiogenesis: Review of current applications in tumor prognostication. Semin Diagn Pathol 10:302, 1993.
7. Gasparini G, Harris AL: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool. J Clin Oncol 13:765, 1995.
8. Heimann R, Ferguson D, Powers C, et al: Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl Cancer Inst 88:1764, 1996.
9. Kato T, Kimura T, Miyakawa R, et al: Clinicopathological study of angiogenesis in Japanese patients with breast cancer. World J Surg 21:49, 1997.
10. Martin L, Green B, Renshaw C, et al: Examining the technique of angiogenesis assessment in invasive breast cancer. Br J Cancer 76:1046, 1997.
11. Cordobes MD, Starzec A, Delmon-Moingeo L, et al: Technetium-99m MIBI uptake by human benign and malignant breast tumor cells: Correlation with mdr gene expression. J Nucl Med 37:286, 1996.
12. Del Vecchio S, Ciarmiello A, Potena MI, et al: In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients. Eur J Nucl Med 24:150, 1997.
13. Del Vecchio S, Ciarmiello A, Pace L, et al: Fractional retention of technetium-99m MIBI as an index of P-glycoprotein expression in untreated breast cancer patients. J Nucl Med 38:1348, 1997.
14. Bom HS, Kim YC, Min JJ, Song HC, Kim JY, Park KO: Tc-99m sestamibi uptake in small cell lung cancer. J Nucl Med 39:91, 1998.
15. Mankoff DA, Dunnwald LK, Gralow JR, et al: Monitoring and predicting the response of breast cancer to neo-adjuvant chemotherapy using [Tc-99m] MIBI scintimammography [Abstract]. J Nucl Med 38:46P, 1997.
16. Ciarmiello A, Del Vecchio S, Carriero MV, et al: Efflux rate of Tc-99m MIBI as a predictor of the outcome of therapy in patients with advanced breast carcinoma [Abstract]. J Nucl Med 38:241P, 1997.